Responding to COVID-19: Highlights of a Survey in ETHIOPIASummary•Almost all Ethiopiansknow about COVID-19 and basic understanding about transmission and the importance of regular hand washing is high. However, a sizeable minority seek more information, which may help address some misconceptions o...n avoidance and ‘cures.’•There is strong support for government response and high levels of trust in information coming from governments.•Ethiopians believe that COVID-19 will be a big problem for their country and that they would be seriously impacted but personally feel at relatively low risk.•Family and friends play an important role in conveying local information.
more
12 May 2021. This third survey in the series shows that the COVID-19 pandemic continues to impact societies, not only in terms of health, but also social and economic conditions and day-to-day life
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
The Lancet DOI: 10.1016/S2468-2667(20)30101-8
WHO declared COVID-19 to be a pandemic on March 11, 2020. The pandemic eventually reached Yemen, with the first laboratory confirmed case announced on April 10. emen has structural vulnerabilities that have developed over a protracted period of conflic...t and poor governance, and its health system has suffered the most. To prevent a total collapse of Yemen’s fragile health system, the government and the international community should act now more decisively.
more
Razum O et al. Covid-19 in Flüchtlingsunterkünften: ÖGD. Gesundheitswesen 2020; 82: 392–396
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future... supply security. In 2021, the AU set a target to produce and supply more than 60% of the vaccine doses on the continent by 2040.
In the last 18 months alone, more than 30 new African manufacturing projects have been announced and estimates indicate that the African vaccine market across all existing and projected novel products could range between US$ 2.8 billion and US$ 5.6 billion by 2040*, demonstrating the potential for a thriving regional industry to emerge.
more
Practice Paper in Brief 19
BMJ 2020;368:m1052 doi: 10.1136/bmj.m1052 (Published 13 March 2020)
IPC Training Day 2
Waste Management & Environmental Cleaning
Plos Current Outbreaks November 21, 2014